AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Sees Significant Increase in Short Interest

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) was the target of a large increase in short interest during the month of May. As of May 29th, there was short interest totaling 1,303,551 shares, an increase of 61.4% from the May 14th total of 807,696 shares. Currently, 5.1% of the shares of the company are short sold. Based on an average daily volume of 583,155 shares, the short-interest ratio is presently 2.2 days.

Institutional Trading of AGF U.S. Market Neutral Anti-Beta Fund

Several hedge funds have recently added to or reduced their stakes in BTAL. Triumph Capital Management acquired a new position in shares of AGF U.S. Market Neutral Anti-Beta Fund during the 3rd quarter worth approximately $70,000. J.Safra Asset Management Corp grew its position in shares of AGF U.S. Market Neutral Anti-Beta Fund by 10.0% during the 4th quarter. J.Safra Asset Management Corp now owns 8,142 shares of the company’s stock worth $117,000 after purchasing an additional 741 shares in the last quarter. IFP Advisors Inc grew its position in shares of AGF U.S. Market Neutral Anti-Beta Fund by 7.4% during the 3rd quarter. IFP Advisors Inc now owns 22,864 shares of the company’s stock worth $364,000 after purchasing an additional 1,582 shares in the last quarter. Worth Asset Management LLC acquired a new position in shares of AGF U.S. Market Neutral Anti-Beta Fund during the 4th quarter worth approximately $364,000. Finally, Bank of New York Mellon Corp grew its position in shares of AGF U.S. Market Neutral Anti-Beta Fund by 59.4% during the 1st quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock worth $380,000 after purchasing an additional 10,146 shares in the last quarter.

AGF U.S. Market Neutral Anti-Beta Fund Stock Performance

NYSEARCA:BTAL traded up $0.04 during mid-day trading on Tuesday, hitting $11.21. 28,612 shares of the stock were exchanged, compared to its average volume of 864,393. The stock has a market capitalization of $288.20 million, a price-to-earnings ratio of 17.67 and a beta of -0.63. The firm’s 50-day simple moving average is $12.32 and its 200 day simple moving average is $13.52. AGF U.S. Market Neutral Anti-Beta Fund has a fifty-two week low of $11.13 and a fifty-two week high of $18.62.

About AGF U.S. Market Neutral Anti-Beta Fund

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.